SOM
SOMNOMED FPO [SOM]
Healthcare · ASX Small Cap
$0.7300 +0.0%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 3 consecutive scans→ Score -2First seen: 2026-02-25
Score Breakdown
Technical55
Catalyst52
Sentiment50
Fundamental88
Momentum67
Risk Gate50
Active Signals
Bullish Signals
- MACD momentum strengthening
- OBV divergence: distribution detected
- Above 200-day MA (long-term uptrend)
- Cash positive / operating cashflow positive
- Low P/S ratio (1.4x)
- Strong revenue growth (+24%)
- EPS estimates revised upward (+10pts)
- CANSLIM I: Institutional ownership (58%)
- Positive 12-1 momentum (+37%)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
- Trial readout: NA (est. 2017-12-31)
Risk Signals
- VPT distribution divergence (bearish)
- Negative profit margins (-3%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
LOW Investor presentation
NONE Half year results announcement FY26
NONE Half Yearly Report and Accounts
NONE 1H FY26 Results Webinar & release date
Recent ASX Announcements
| 2026-02-26 | Investor presentation PRICE SENSITIVE |
| 2026-02-26 | Half year results announcement FY26 PRICE SENSITIVE |
| 2026-02-26 | Half Yearly Report and Accounts PRICE SENSITIVE |
| 2026-02-13 | 1H FY26 Results Webinar & release date |
| 2026-01-13 | Application for quotation of securities - SOM |
Key Metrics
$159.5M
Market Cap
24K
Avg Volume
1.5x
Vol Ratio
$0.37 — $0.94
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-7.6%
ROE
-3.1%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 52% |
| L | Leader vs Laggard | laggard | RS: -2 |
| I | Institutional Sponsorship | pass | Inst: 58% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #62 of 119 · Sector avg: 51
View all Healthcare signals →